Latest News from the Lupus Research Institute

LRI Hosts First International Conference to Advance New Treatments for Lupus Nephritis

Wed, 22 May 2013 17:12:00 -0500

Launches Global Lupus Nephritis Trials Network

The Lupus Research Institute (LRI) today is hosting the first international conference devoted to advancing new treatments for lupus nephritis, a serious kidney complication of lupus affecting up to 60 percent of patients. The conference launched a new international alliance of researchers specializing in lupus nephritis - the Lupus Nephritis Trials Network (LNTN).

LRI National Patient Coalition Advocacy Culminates in Launch of Federal Provider Education Program

Thu, 16 May 2013 09:48:09 -0500

Singer Toni Braxton Shares Personal Story of Lupus

The Lupus Research Institute (LRI) National Patient Coalition participated in today's launch of the Lupus Initiative^®, the culmination of its five-year advocacy campaign resulting in $4.6 million in Federal funding to make the healthcare provider education program possible.

New studies Outline Cardiovascular Risk in Lupus Patients

Tue, 14 May 2013 16:23:15 -0500

Several studies presented at a recent international lupus conference provide different approaches to identify risk for cardiovascular episodes related to lupus. Dr. Michelle Petri of Johns Hopkins University, Baltimore, presented data supporting a novel risk-assessment formula to calculate the 10-year risk of a cardiovascular event (CVE).

Oxford Gene Technology Developed Novel Biomarker for Improved Lupus Diagnosis

Tue, 14 May 2013 16:21:25 -0500

The British company Oxford Gene Technology (OGT) announced the development of a novel biomarker panel to improve diagnosis of lupus.

The biomarker panel has been rigorously tested among samples from North American, European and Afro-Caribbean lupus patients and shown to be Our more sensitive and specific than existing laboratory tests.

New Studies at Lupus Conference Show Progress in Pediatric Lupus

Tue, 14 May 2013 16:20:02 -0500

A group of new studies on juvenile-onset systemic lupus erythematosus suggests that investigators are gaining a foothold on noninvasively monitoring renal disease, making more accurate diagnoses, and determining the prevalence of hippocampal atrophy in adolescents with the condition.

Lupus Research Institute Tops $170 Million for Novel Research in Lupus

Wed, 01 May 2013 09:24:00 -0500

Unsurpassed Support Produces Breakthrough Discoveries Changing Patients’ Lives

NEW YORK, NY – May 1 – The Lupus Research Institute (LRI) announces a new $170 million milestone — delivering unprecedented novel research funding and unprecedented research results — changing the lives of lupus patients. A new analysis of completed LRI Novel Research grants demonstrates an 84 percent success rate as scientists prove cutting-edge hypotheses, publish results and win extended federal funding to advance original discoveries to clinical development.

Lupus Research Institute and the S.L.E. Lupus Foundation Address Global Treatment Issues for World Lupus Awareness Day

Wed, 01 May 2013 08:45:52 -0500